Background: Dermatophytosis has evolved into a major therapeutic challenge with the global emergence of Trichophyton indotineae, a pathogen associated with chronic, recurrent, and treatment-refractory infections. The widespread emergence of antifungal resistance, particularly to terbinafine and, increasingly, itraconaz...
K. Sardana, S. Sharath, Ananta Khurana· Pharmaceuticals· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.